Riverwater Partners’s Meridian Bioscience Inc VIVO Stock Holding History

Riverwater Partners’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,473	Closed	-$281K	–	215
2022 Q4	$281K	Hold	8,473	–	–	0.24%	134
2022 Q3	$267K	Sell	8,473 -5,476	-39%	-$177K	0.27%	130
2022 Q2	$424K	Buy	13,949 +7	+0.1%	+$189	0.43%	75
2022 Q1	$362K	Buy	13,942 +4	+0%	+$95	0.6%	75
2021 Q4	$284K	Buy	+13,938	New	+$267K	0.25%	161

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Riverwater Partners's VIVO Position: Q1 2023 in Review

Riverwater Partners sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 8,473 shares — an estimated $281K sold.

Riverwater Partners first reported a position in VIVO in Q4 2021 and held it in 5 quarters. The position peaked at $424K in Q2 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Riverwater Partners reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Riverwater Partners sold 8,473 Meridian Bioscience Inc shares in Q1 2023, an estimated $281K.
Riverwater Partners first reported a position in Meridian Bioscience Inc in Q4 2021 and held it in 5 quarters.
Riverwater Partners's Meridian Bioscience Inc position peaked at $424K in Q2 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Riverwater Partners's 13F filing for Q1 2023, filed 12 Apr 2023.